Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martine de Champvallins"'
Autor:
John Chalmers, Jean-Jacques Mourad, Romualda Brzozowska-Villatte, Martine De Champvallins, Giuseppe Mancia
Publikováno v:
Journal of Hypertension. 41:508-515
Autor:
Martine de Champvallins, Yuri Karpov, Csaba András Dézsi, Csaba Farsang, M G Glezer, Romualda Brzozowska-Villatte
Publikováno v:
Advances in Therapy
Introduction To assess real-life effectiveness of a perindopril/indapamide (Per/Ind) single-pill combination (SPC) in patients with hypertension (HT) and type 2 diabetes mellitus (T2DM), obesity and/or metabolic syndrome (MetS). Methods This post hoc
Publikováno v:
Journal of hypertension. 38(4)
Autor:
Celso Amodeo, Jean-Jacques Mourad, Martine de Champvallins, Romualda Brzozowska-Villatte, Roland Asmar
Publikováno v:
Journal of Hypertension. 35:1481-1495
This 4-month, double-blind, randomized, controlled trial was designed to demonstrate the superiority of perindopril/indapamide/amlodipine single pill over perindopril/indapamide after 1 month and to determine further up-titration efficacy and safety
Objectives: The current international, 12-week, double-blind, randomized, controlled trial assessed the efficacy and safety of indapamide sustained release/amlodipine single-pill combination (SPC) in mild-to-moderate hypertensive patients.\ud \ud Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8623496fa8f783e62309c2707141887
https://eprints.gla.ac.uk/187655/1/187655.pdf
https://eprints.gla.ac.uk/187655/1/187655.pdf
Autor:
Nicolas Deltour, Karine Marinier, Pauline Macouillard, Neil R Poulter, Giuseppe Mancia, Martine de Champvallins
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose To compare the effectiveness on blood pressure (BP) of initial two‐drug therapy versus monotherapy in hypertensive patients. Methods Using the Clinical Practice Research Datalink, linked with Hospital Episode Statistics and Office for Natio
Publikováno v:
Metabolism: clinical and experimental. 46(12 Suppl 1)
Five thousand five hundred seventy-two newly diagnosed non-insulin-dependent diabetes mellitus (NIDDM) patients (3,225 men and 2,347 women; mean age, 58.5 years) were recruited through the General Practitioners (GPs) network in France. All had persis